Antiarrhythmic Drug Therapy in 2012 Time to Finally Open Our Eyes! Reply

被引:0
作者
Saksena, Sanjeev
机构
关键词
ATRIAL-FIBRILLATION; MANAGEMENT; OUTCOMES; RHYTHM;
D O I
10.1016/j.jacc.2011.11.043
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1040 / 1041
页数:3
相关论文
共 4 条
  • [1] Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation
    Freemantle, Nick
    Lafuente-Lafuente, Carmelo
    Mitchell, Stephen
    Eckert, Laurent
    Reynolds, Matthew
    [J]. EUROPACE, 2011, 13 (03): : 329 - 345
  • [2] Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation -: A systematic review of randomized controlled trials
    Lafuente-Lafuente, C
    Mouly, S
    Longás-Tejero, MA
    Mahé, I
    Bergmann, JF
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (07) : 719 - U5
  • [3] Cardiovascular Outcomes in the AFFIRM Trial (Atrial Fibrillation Follow-Up Investigation of Rhythm Management) An Assessment of Individual Antiarrhythmic Drug Therapies Compared With Rate Control With Propensity Score-Matched Analyses
    Saksena, Sanjeev
    Slee, April
    Waldo, Albert L.
    Freemantle, Nick
    Reynolds, Mathew
    Rosenberg, Yves
    Rathod, Snehal
    Grant, Shannon
    Thomas, Elizabeth
    Wyse, D. George
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (19) : 1975 - 1985
  • [4] IMPACT OF NON-PHARMACOLOGIC THERAPIES ON CLINICAL OUTCOMES OF A RATE CONTROL STRATEGY: AN AFFIRM ANALYSIS
    Saksena, Sanjeev
    Slee, April
    Liu, Tina
    Verma, Ankush
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E128 - E128